David M. Knott’s GSK GSK Stock Holding History

David M. Knott’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-18,080	Closed	-$883K	–	113
2018 Q1	$883K	Hold	18,080	–	–	0.36%	40
2017 Q4	$802K	Hold	18,080	–	–	0.32%	40
2017 Q3	$918K	Hold	18,080	–	–	0.39%	26
2017 Q2	$975K	Hold	18,080	–	–	0.41%	25
2017 Q1	$953K	Hold	18,080	–	–	0.46%	22
2016 Q4	$870K	Hold	18,080	–	–	0.44%	22
2016 Q3	$975K	Hold	18,080	–	–	0.5%	20
2016 Q2	$979K	Hold	18,080	–	–	0.23%	34
2016 Q1	$916K	Hold	18,080	–	–	0.24%	37
2015 Q4	$912K	Hold	18,080	–	–	0.25%	37
2015 Q3	$869K	Hold	18,080	–	–	0.25%	36
2015 Q2	$941K	Hold	18,080	–	–	0.19%	40
2015 Q1	$1.04M	Buy	18,080 +880	+5%	+$50.5K	0.22%	39
2014 Q4	$919K	Buy	+17,200	New	+$962K	0.22%	41

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

David M. Knott's GSK Position: Q2 2018 in Review

David M. Knott sold out of GSK (GSK) in Q2 2018, closing a stake of 18,080 shares — an estimated $883K sold.

David M. Knott first reported a position in GSK in Q4 2014 and held it in 14 quarters. The position peaked at $1.04M in Q1 2015. 788 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

David M. Knott reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
David M. Knott sold 18,080 GSK shares in Q2 2018, an estimated $883K.
David M. Knott first reported a position in GSK in Q4 2014 and held it in 14 quarters.
David M. Knott's GSK position peaked at $1.04M in Q1 2015.
788 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on David M. Knott's 13F filing for Q2 2018, filed 13 Aug 2018.